Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Study on drug sensitivity patterns in tuberculosis in tertiary care in Mumbai

Namrata Saxena, Vikas Agarwal, Amita Nene
European Respiratory Journal 2016 48: PA2679; DOI: 10.1183/13993003.congress-2016.PA2679
Namrata Saxena
1Chest Medicine, Bombay Hospital and Institute of Medical Science, Mumbai, MaharashtraIndia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vikas Agarwal
1Chest Medicine, Bombay Hospital and Institute of Medical Science, Mumbai, MaharashtraIndia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amita Nene
1Chest Medicine, Bombay Hospital and Institute of Medical Science, Mumbai, MaharashtraIndia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Introduction: Currently available reports of Multi Drug Resistance(MDR) & Extensively Drug Resistance Tuberculosis(XDR-TB) prevalence are underestimated because drug-susceptibility testing (DST) is incomplete and surveillance data are lacking from many nations.

Aims: To analyze the drug resistance pattern among TB patients in a Tertiary care in Mumbai

Methods: This is a Prospective study done over period of June 2010 to December 2011.Total of 181 patients MTB Culture Positive were included. DST was done by Bactec MGIT 960.The samples were subjected to DST for the following thirteen drugs with the recommended critical concentrations: Isoniazid, Rifampicin, Pyrazinamide(PZA), Ethambutol, Streptomycin, Amikacin, Kanamycin, Capreomycin, Ofloxacin(OFX), Moxifloxacin, Ethionamide, Para-aminosalicylic acid, and Clofazimine(CFZ).

Result: Out of 181 total patients 83(45.8%) were found to be MDR-TB and 10(5.5%) were XDR-TB. Resistance either to any individual drug or in combination with other drugs was highest for Isoniazid (105, 58.01%), followed by Streptomycin (86, 47.51%), Rifampicin (85, 46.96%), Ethambutol (65, 35.91%), Pyrazinamide (62, 34.25%), Ofloxacin (61, 33.7%), Ethionamide (55, 30.39%), Moxifloxacin (46, 25.41%), Para-aminosalicylic acid (18, 9.94%), Kanamycin (11, 6.08%), Amikacin (10, 5.52%), Capreomycin (10, 5.52%). None of the patient showed resistance to CFZConclusion High resistance to OFX may probably be due to inappropriate use of fluoroquinolone as broad-spectrum antibiotics. High resistance to second line drugs may be due to its is widespread and unchecked prescription. No resistance to CFZ could probably be due to very little ability of MTB to develop resistance to CFZ.

  • MDR-TB
  • Tuberculosis - management
  • Treatments
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Study on drug sensitivity patterns in tuberculosis in tertiary care in Mumbai
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Study on drug sensitivity patterns in tuberculosis in tertiary care in Mumbai
Namrata Saxena, Vikas Agarwal, Amita Nene
European Respiratory Journal Sep 2016, 48 (suppl 60) PA2679; DOI: 10.1183/13993003.congress-2016.PA2679

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Study on drug sensitivity patterns in tuberculosis in tertiary care in Mumbai
Namrata Saxena, Vikas Agarwal, Amita Nene
European Respiratory Journal Sep 2016, 48 (suppl 60) PA2679; DOI: 10.1183/13993003.congress-2016.PA2679
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Experience of managing TB/HIV infection in a regional UK center over a 5 year period
  • Annual FEV1 change : Post tuberculosis obstructive airway disease versus COPD
Show more 10.2 Tuberculosis

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society